ChromaDex Corp. (CDXC.OB) Receives $500,000 Grant to Commercialize Antioxidant Technology
ChromaDex Corp., a leading developer of phytochemical and botanical reference standards and analytical tools and services, today announced that the National Science Foundation has awarded the company a $500,000 phase II Small Business Innovation Research (SBIR) Grant for the company’s project called “SBIR Phase II: Microbial Production of Selected Anthocyanins.” The grant will enable the company to continue with the commercial development of several plant-based antioxidants called anthocyanins for use in nutraceutical, food, beverage and cosmetic products. ChromaDex will combine the grant money with its own resources to complete validation of anthocyanins using its AnthoPure™ technology to meet growing demand…